502 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
21 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
22 Unknown  Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
23 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
24 Recruiting Therapy With New Oral Anticoagulants
Conditions: Atrial Fibrillation;   Non-valvular Atrial Fibrillation
Intervention:
25 Unknown  D-Dimer Guided Oral Anticoagulant Treatment (OAT)
Condition: Deep Venous Thrombosis
Interventions: Drug: Phenprocoumon;   Drug: Warfarin-Natrium
26 Recruiting Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
27 Recruiting Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
Condition: Hematoma
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Apixaban
28 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
29 Recruiting Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
Condition: Benign Prostatic Hyperplasia
Intervention:
30 Recruiting Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)
Conditions: Secondary Prevention;   Stroke;   Ischemic Heart Disease;   Coronary Heart Disease
Interventions: Drug: Acetylsalicylic Acid (Asprin, BAYE4465);   Drug: Clopidogrel, Oral Anticoagulants, NSAIDs and SSRIs
31 Not yet recruiting Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis
Conditions: Symptomatic Aortic Stenosis;   Eligible for Transcatheter Aortic Valve Replacement
Interventions: Drug: Apixaban;   Drug: Standard of care
32 Recruiting Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Condition: Unsuspected Pulmonary Embolism
Intervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
33 Recruiting Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
34 Recruiting Register for New Oral Anticoagulants
Condition: Anticoagulation Treatment
Intervention:
35 Recruiting Sequential Expansion of Comparative Effectiveness of Anticoagulants
Condition: Atrial Fibrillation
Intervention:
36 Unknown  Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent
Condition: Healthy
Intervention: Drug: Indobufen
37 Recruiting Reversal of Dabigatran Anticoagulant Effect With Idarucizumab
Condition: Hemorrhage
Intervention: Drug: idarucizumab
38 Not yet recruiting Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
Condition: Atrial High Rate Episodes
Interventions: Drug: Edoxaban;   Drug: ASA
39 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
40 Recruiting A Study in Patients With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants
Condition: Bleeding
Intervention: Biological: Andexanet

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years